Will Remdesivir turn out to be Fauci's new AZT?
A second more disturbing announcement reached the public in the summer of 1989. NIAID, the NIH division under Anthony Fauci, declared it would be conducting trials of AZT in pregnant mothers infected with HIV. A drug that interferes with growth can lead only to physical deformities in babies developing in the womb...However to prescribe a known mutagenic drug to a pregnant woman was a risky departure from the foremost medical principle, “First, do no harm.”...
In February 1994, Fauci’s American-French trial on pregnant woman was abruptly terminated. Fauci and his collaborators claimed victory because AZT had reduced “material HIV transmission rate by 2/3” --- from 25% without treatment to 8% with AZT treatment... [But] In view of the possible genetic damage from AZT, Fauci acknowledged “long-term follow up of all of the children...is essential to learn more about the risks and benefits beyond their encouraging results.”...
After declating victory against HIV transmission, the double-blind trials were officially broken prematurely and AZT was offered to all mothers...
An editorial in Lancet did not share Faucet’s optimisim: “The most worrisome aspect is the possibility of long-term adverse effects of children exposed to Zidovudine (AZT) during fetal life, especially since the vast majority wouldn’t have been infected anyway.”
Source: What You Don't Know About Dr. Tony Fauci
https://www.targetliberty.com/2020/04/what-you-dont-know-dr-tony-fauci-show.html